The B.R.I.C. Markets for Endoscopic Devices includes: Brazil, Russia, India and China. These markets also include: ENT endoscopes, bronchoscopes, colonoscopes, duodenoscopes, enteroscopes, ultrasound endoscopes, urological endoscopes and GI endoscopes. In 2008, Russia was the fastest growing market in the B.R.I.C. Markets for Endoscopic Devices, growing 23% over 2007. Brazil, India and China also showed strong growth rates.
Palomar Medical Technologies, Inc. (Nasdaq: PMTI), is pleased to announce the immediate availability of the Groove Optic for the Lux2940 fractional handpiece. The new optic represents a significant advancement in fractional ablative skin resurfacing by creating a unique, grooved injury pattern on skin that increases ablative tissue coverage while preserving the benefits of fractional approaches.
Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the United States. In conjunction with the announcement, Smith & Nephew will host a panel discussion today about hysteroscopy at this year's American Association of Gynecologic Laparoscopists (AAGL) annual meeting, which is being held in Orlando, Fla. The inventor of the TRUCLEAR System, Mark Hans Emanuel, M.D., Department of Obstetrics and Gynecology, Spaarne Hospital, The Netherlands, will chair the panel discussion.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials. Perceptive has incorporated into its medical imaging technologies components of Hermes Medical Solutions Nuclear Medicine Software Suite and INVIA's Corridor4DM, a solution for nuclear cardiac quantification and imaging. The solutions allow Perceptive to better integrate several imaging modalities, including Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Multi Gated Acquisition Scan (MUGA) to enhance electronic processing, review, analysis, reporting, and archiving of medical images for cardiology trials.
Agilent Technologies Inc. (NYSE: A) today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents. Agilent will use MassCode Tag technology to develop new research products for pathogen identification, leveraging its strength in polymerase chain reaction (PCR) and mass spectroscopy. Under the agreement, Eurofins MWG Operon will continue as a supplier of the core component for the new products.
A team led by Yale University scientists has developed a new approach to studying how immune cells chase down bacteria in our bodies
The motion we perceive with our eyes plays a critical role in guiding our feet as we move through the world, Brown University research shows.
Dishler Laser Institute announced today that Dr. Jon Dishler has been selected by Goldline Research as one of the leading Laser Eye Surgeons of the United States for 2009. The list of leading Laser Eye Surgeons of the United States is scheduled to be published in the November 30th issue of Forbes Magazine.
Retail sales of contact lenses within the West Coast of Malaysia grew steadily in the first half of 2009 with total consumption peaking in June, driven by improving consumer sentiment and aggressive promotions from major Contact Lens manufacturers. Positive sales data showing a growth of 14% from January 2009 ending August further cemented the view of an economic recovery that is being led by consumers spending.
An Orange County Superior Court Judge has certified a class action against Abbott Medical Optics, Inc., on behalf of all California consumers who purchased a contact lens solution the Centers for Disease Control have linked to a parasitic infection that can cause blindness or the complete loss of an eye.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.